Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123069 · ClinicalTrials.gov registry record
Vascular Function and Uterine Fibroids
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 28
- Enrollment target
NCT02123069: Completed study, sponsored by Mayo Clinic.
NCT02123069 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02123069 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how uterine fibroids may be connected to heart disease and high blood pressure. It is not known what causes fibroids, but they frequently occur in women who also have high blood pressure, heart disease, and stroke. The investigators of this study want to learn if certain changes in the blood vessels or nerve activity can put women at risk for these diseases and for fibroids.
Interventions
- DRUG Norepinephrine
- DRUG Acetylcholine
- DRUG Nitroprusside
- DEVICE Brachial artery catheter
- DRUG Nitroprusside and phenylephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02123069
The ClinicalTrials.gov registry entry for NCT02123069 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Norepinephrine is the first listed.
NCT02123069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02123069 about?
NCT02123069 is a clinical study titled "Vascular Function and Uterine Fibroids". The purpose of this study is to learn how uterine fibroids may be connected to heart disease and high blood pressure. It is not known what causes fibroids, but they frequently occur in women who also have high blood pressure, heart disease, and stroke. The investigators of this study want to learn i...
What is the current status of trial NCT02123069?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2013-04. Estimated completion is 2018-03-01.
What interventions are being tested in trial NCT02123069?
The interventions under investigation include: Norepinephrine (DRUG), Acetylcholine (DRUG), Nitroprusside (DRUG), Brachial artery catheter (DEVICE), Nitroprusside and phenylephrine (DRUG).
Who is sponsoring clinical trial NCT02123069?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.